Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. The company pioneers antibody-based formats such as bispecific antibodies, antibody-drug conjugates and immune-modulating antibodies, and advances a strong clinical pipeline with the goal of delivering transformative medicines to patients. Genmab is headquartered in Copenhagen, Denmark, and has an international presence across North America, Europe and Asia Pacific.

Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. The company pioneers antibody-based formats such as bispecific antibodies, antibody-drug conjugates and immune-modulating antibodies, and advances a strong clinical pipeline with the goal of delivering transformative medicines to patients. Genmab is headquartered in Copenhagen, Denmark, and has an international presence across North America, Europe and Asia Pacific.